Emerging Biology of PDE10A

E-ISSN： 1873-4286|21|3|378-388

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 378-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging concepts in cardiac matrix biology

By Espira Leon Czubryt Michael P.

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 12, 2009-12 ,pp. : 996-1008

NRC Research Press

Access to resources Recommend Favorite

Combined treatment with a selective PDE10A inhibitor TAK‐063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic‐like effects without affecting plasma prolactin levels and cataleptic responses in rodents

Pharmacology Research & Perspectives, Vol. 6, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

PDE7 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 601-603

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibitors 1998

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 771-784

Informa Healthcare

Access to resources Recommend Favorite